Table 3 Distribution of inhaler score differences of patients in intervention 1 and intervention 2 groups

Intervention 1 group (n=32)

First follow-up

M (Q₁–Q₃)

6.0 (5.0–7.0)

6.0 (5.5–8.0)

6.0 (5.5–7.5)

6.5 (5.25–7.0)

Last follow-up

M (Q₁–Q₃)

10.0 (10.0–10.0)

10.0 (10.0–10.0)

10.0 (10.0–10.0)

10.0 (10.0–10.0)

Difference*

M (Q₁–Q₃)

4.0 (5.0–3.0)

4.0 (4.5–1.5)

4.0 (4.5–2.5)

3.5 (4.75–3.0)

p**

<0.001

<0.001

<0.001

0.002

Intervention 2 group (n=35)

First follow-up

M (Q₁–Q₃)

5.0 (4.0–7.0)

6.0 (5.0–7.0)

6.5 (6.0–8.0)

6.0 (5.5–7.5)

Last follow-up

M (Q₁–Q₃)

10.0 (9.0–10.0)

10.0 (9.0–10.0)

10.0 (9.0–10.0)

10.0 (9.0–10.0)

Difference*

M (Q₁–Q₃)

5.0 (5.0–3.0)

3.0 (4.0–3.0)

3.0 (3.75–2.0)

3.0 (4.5–2.5)

p**

<0.001

<0.001

0.003

0.002

0.464

0.953

0.173

0.390

0.306

0.632

0.460

0.932